Skip to content

Innoviva, Inc. INVA Intangible Amortization

Intangible Amortization at other companies

Insmed logo
InsmedINSM
$2.08M+64.8%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$40K-34.4%
Zymeworks logo
ZymeworksZYME
$176K-89.1%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$5.72M+4.0%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s intangible amortization?
Innoviva, Inc. (INVA) reported intangible amortization of $6.55M in Q1 2026.
How has Innoviva, Inc.'s intangible amortization changed year-over-year?
Innoviva, Inc.'s intangible amortization increased by 1.2% year-over-year, from $6.48M to $6.55M.
What does intangible amortization mean?
Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.